Veracyte, Inc. Common Stock (VCYT) Stock
NASDAQ · VCYT
41.52
Fundamentals
Market cap
$3.20B
Price / Earnings ratio
27.9x
Price / Sales ratio
5.7x
Price / Book ratio
2.3x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Veracyte, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees755
CEOMr. Marc A. Stapley
IPO DateOct 30, 2013
HeadquartersSouth San Francisco, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Marc A. Stapley | CEO & Director | 1970 |
| Ms. Rebecca Chambers | Executive VP & CFO | 1978 |
| Dr. Phillip G. Febbo M.D. | Chief Scientific & Medical Officer | 1966 |
| Ms. Annie McGuire | Executive VP, General Counsel & Head of Market Access | 1980 |
| Dr. John Leite Ph.D. | Global Chief Commercial Officer | 1972 |
| Dr. Keith Gligorich Ph.D. | Senior Vice President of Global Operations | — |
| Mr. Jonathan Wygant | VP & Chief Accounting Officer | 1971 |
| Dr. Kevin Richard Haas Ph.D. | Chief Development & Technology Officer | 1985 |
| Mr. Steven French | Senior VP & Chief Information Officer | — |
| Ms. Kelly Gura | Director of Investor Relations | — |
Fundamentals
Valuation
Market cap$3.20B
Price-to-sales ratio5.69
Price-to-book value2.30
Price-earnings ratio27.90
Return on Equity7.00%
Return on Sales0.17%
Return on Assets0.06%
PEG ratio0.00
Earnings Per Share
Earnings Per Share$1.44
Income Statement
Average volume1,336,025
EBITDA$115.05M
1 year high (52w)$60.91
1 year low (52w)$29.46
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



